AAP
Arax Advisory Partners Portfolio holdings
AUM
$2.18B
1-Year Return
13.41%
This Quarter Return
+8.03%
1 Year Return
+13.41%
3 Year Return
+43.76%
5 Year Return
–
10 Year Return
–
AUM
$2.18B
AUM Growth
+$616M
(+40%)
Cap. Flow
+$297M
Cap. Flow
% of AUM
13.67%
Top 10 Holdings %
Top 10 Hldgs %
22.84%
Holding
3,222
New
564
Increased
1,310
Reduced
679
Closed
193
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
+$38.1M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$31.7M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
+$24.5M |
| 4 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$22.5M |
| 5 |
iShares S&P 500 Growth ETF
IVW
|
+$21.9M |
Top Sells
| 1 |
iShares S&P 500 Value ETF
IVE
|
+$71.8M |
| 2 |
iShares Russell Mid-Cap Growth ETF
IWP
|
+$29M |
| 3 |
SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
|
+$21.9M |
| 4 |
iShares Ultra Short Duration Bond Active ETF
ICSH
|
+$19.2M |
| 5 |
Invesco Ultra Short Duration ETF
GSY
|
+$19.1M |
Sector Composition
| 1 | Technology | 6.5% |
| 2 | Financials | 4.24% |
| 3 | Healthcare | 3.21% |
| 4 | Consumer Discretionary | 2.76% |
| 5 | Industrials | 2.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2551
Supernus Pharmaceuticals
SUPN
$2.62B
| $2.14K | ﹤0.01% |
68
+26
| +62% | +$819 |
|
2552
Flywire
FLYW
$1.68B
| $2.14K | ﹤0.01% |
63
-74
| -54% | -$2.52K |
|
2553
Arvinas
ARVN
$573M
| $2.13K | ﹤0.01% |
+289
| New | +$2.13K |
|
2554
X4 Pharmaceuticals
XFOR
$74.1M
| $2.13K | ﹤0.01% |
+1,120
| New | +$2.13K |
|
2555
Dine Brands
DIN
$372M
| $2.12K | ﹤0.01% |
87
+26
| +43% | +$633 |
|
2556
Humacyte
HUMA
$238M
| $2.09K | ﹤0.01% |
1,000
| – | – |
|
2557
Myers Industries
MYE
$612M
| $2.09K | ﹤0.01% |
144
-29
| -17% | -$420 |
|
2558
Boise Cascade
BCC
$3.32B
| $2.08K | ﹤0.01% |
24
-50
| -68% | -$4.34K |
|
2559
ProFrac Holding
ACDC
$698M
| $2.07K | ﹤0.01% |
267
+81
| +44% | +$629 |
|
2560
Franklin Electric
FELE
$4.31B
| $2.07K | ﹤0.01% |
23
+6
| +35% | +$539 |
|
2561
Ubiquiti
UI
$37.1B
| $2.06K | ﹤0.01% |
5
-2
| -29% | -$824 |
|
2562
West Bancorporation
WTBA
$350M
| $2.02K | ﹤0.01% |
103
+49
| +91% | +$962 |
|
2563
Helios Technologies
HLIO
$1.85B
| $2K | ﹤0.01% |
+60
| New | +$2K |
|
2564
Ultragenyx Pharmaceutical
RARE
$3.01B
| $2K | ﹤0.01% |
55
-23
| -29% | -$836 |
|
2565
Hovnanian Enterprises
HOV
$917M
| $1.99K | ﹤0.01% |
+19
| New | +$1.99K |
|
2566
Vir Biotechnology
VIR
$727M
| $1.99K | ﹤0.01% |
394
+276
| +234% | +$1.39K |
|
2567
La-Z-Boy
LZB
$1.44B
| $1.97K | ﹤0.01% |
53
+35
| +194% | +$1.3K |
|
2568
Alamo Group
ALG
$2.56B
| $1.97K | ﹤0.01% |
9
-11
| -55% | -$2.4K |
|
2569
Fortuna Silver Mines
FSM
$2.59B
| $1.96K | ﹤0.01% |
300
| – | – |
|
2570
Madison Square Garden
MSGE
$2.06B
| $1.96K | ﹤0.01% |
49
| – | – |
|
2571
PTC Therapeutics
PTCT
$4.84B
| $1.95K | ﹤0.01% |
+40
| New | +$1.95K |
|
2572
Liberty Live Group Series C
LLYVK
$9.36B
| $1.95K | ﹤0.01% |
24
+5
| +26% | +$406 |
|
2573
Fidelity MSCI Real Estate Index ETF
FREL
$1.07B
| $1.95K | ﹤0.01% |
+72
| New | +$1.95K |
|
2574
Syndax Pharmaceuticals
SNDX
$1.41B
| $1.94K | ﹤0.01% |
+207
| New | +$1.94K |
|
|
ONC
2575
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.9B
| $1.94K | ﹤0.01% |
8
-5
| -38% | -$1.21K |
|